BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17049266)

  • 1. Increased yield of high purity recombinant human interferon-gamma utilizing reversed phase column chromatography.
    Reddy PK; Reddy SG; Narala VR; Majee SS; Konda S; Gunwar S; Reddy RC
    Protein Expr Purif; 2007 Mar; 52(1):123-30. PubMed ID: 17049266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preparation and identification of recombinant human interferon-gamma].
    Wu D; Gao D; Bai Q; Geng X
    Se Pu; 2008 Mar; 26(2):206-11. PubMed ID: 18581854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Method for increasing the yield of properly folded recombinant human gamma interferon from inclusion bodies.
    Arora D; Khanna N
    J Biotechnol; 1996 Dec; 52(2):127-33. PubMed ID: 9084211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased yield of high-purity and active tetrameric recombinant human EC-SOD by solid phase refolding.
    Ryu K; Kim YH; Kim Y; Lee JS; Jeon B; Kim TY
    J Microbiol Biotechnol; 2008 Oct; 18(10):1648-54. PubMed ID: 18955813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving purification of recombinant human interferon gamma expressed in Escherichia coli; effect of removal of impurity on the process yield.
    Mohammadian-Mosaabadi J; Naderi-Manesh H; Maghsoudi N; Nassiri-Khalili MA; Masoumian MR; Malek-Sabet N
    Protein Expr Purif; 2007 Feb; 51(2):147-56. PubMed ID: 16908190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refolding and purification of interferon-gamma in industry by hydrophobic interaction chromatography.
    Geng X; Bai Q; Zhang Y; Li X; Wu D
    J Biotechnol; 2004 Sep; 113(1-3):137-49. PubMed ID: 15380653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production, purification, and chemical stability of recombinant human interferon-γ in low oxygen tension condition: a formulation approach.
    Malek-Sabet N; Masoumian MR; Zeinali M; Khalilzadeh R; Mousaabadi JM
    Prep Biochem Biotechnol; 2013; 43(6):586-600. PubMed ID: 23742090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production, purification and characterization of recombinant human interferon gamma.
    Zhang Z; Tong KT; Belew M; Pettersson T; Janson JC
    J Chromatogr; 1992 Jun; 604(1):143-55. PubMed ID: 1639923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On-column refolding of recombinant human interferon-gamma with an immobilized chaperone fragment.
    Gao YG; Guan YX; Yao SJ; Cho MG
    Biotechnol Prog; 2003; 19(3):915-20. PubMed ID: 12790657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and refolding of recombinant human interferon-gamma in urea-ammonium chloride solution.
    Petrov S; Nacheva G; Ivanov I
    Protein Expr Purif; 2010 Sep; 73(1):70-3. PubMed ID: 20363329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On-column refolding of recombinant human interferon-gamma inclusion bodies by expanded bed adsorption chromatography.
    Jin T; Guan YX; Yao SJ; Lin DQ; Cho MG
    Biotechnol Bioeng; 2006 Mar; 93(4):755-60. PubMed ID: 16261630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of mobile phase on the mass recovery of rhIFN-gamma in protein folding liquid chromatography].
    Wu D; Wang C; Geng X
    Se Pu; 2007 Mar; 25(2):197-202. PubMed ID: 17580685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oxidative stress on the production of recombinant human interferon-gamma in Escherichia coli.
    Mohammadian-Mosaabadi J; Naderi-Manesh H; Maghsoudi N; Khalilzadeh R; Shojaosadati SA; Ebrahimi M
    Biotechnol Appl Biochem; 2005 Feb; 41(Pt 1):37-42. PubMed ID: 15030320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromatographic refolding of recombinant human interferon gamma by an immobilized sht GroEL191-345 column.
    Guan YX; Fei ZZ; Luo M; Jin T; Yao SJ
    J Chromatogr A; 2006 Feb; 1107(1-2):192-7. PubMed ID: 16427063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of a monolithic column for weak cation exchange chromatography and its application in the separation of biopolymers.
    Wei Y; Huang X; Liu R; Shen Y; Geng X
    J Sep Sci; 2006 Jan; 29(1):5-13. PubMed ID: 16485704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression of chaperonin GroEL/GroES markedly enhanced soluble and functional expression of recombinant human interferon-gamma in Escherichia coli.
    Yan X; Hu S; Guan YX; Yao SJ
    Appl Microbiol Biotechnol; 2012 Feb; 93(3):1065-74. PubMed ID: 21975693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of aggregation prone human interferon gamma and its mutant in highly soluble and biologically active form by SUMO fusion technology.
    Tileva M; Krachmarova E; Ivanov I; Maskos K; Nacheva G
    Protein Expr Purif; 2016 Jan; 117():26-34. PubMed ID: 26407523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An approach for increasing the mass recovery of proteins derived from inclusion bodies in biotechnology.
    Wu D; Wang C; Geng X
    Biotechnol Prog; 2007; 23(2):407-12. PubMed ID: 17373822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning, high expression and purification of recombinant human intereferon-beta-1b in Escherichia coli.
    Rao DV; Ramu CT; Rao JV; Narasu ML; Rao AK
    Appl Biochem Biotechnol; 2009 Jul; 158(1):140-54. PubMed ID: 18679594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple and efficient method for the purification of human gamma interferon.
    Braude IA
    Prep Biochem; 1983; 13(3):177-90. PubMed ID: 6415649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.